Acadian Asset Management’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,851
| Closed | -$5K | – | 2044 |
|
2024
Q3 | $5K | Hold |
2,851
| – | – | ﹤0.01% | 2037 |
|
2024
Q2 | $5K | Sell |
2,851
-738
| -21% | -$1.29K | ﹤0.01% | 1716 |
|
2024
Q1 | $8K | Sell |
3,589
-1,200
| -25% | -$2.68K | ﹤0.01% | 1522 |
|
2023
Q4 | $10K | Sell |
4,789
-2,337
| -33% | -$4.88K | ﹤0.01% | 1623 |
|
2023
Q3 | $14K | Hold |
7,126
| – | – | ﹤0.01% | 1580 |
|
2023
Q2 | $20K | Sell |
7,126
-2,138
| -23% | -$6K | ﹤0.01% | 1645 |
|
2023
Q1 | $26K | Buy |
+9,264
| New | +$26K | ﹤0.01% | 1622 |
|